Skip to main content
NCBI home page
Annals of Oncology logoLink to Annals of Oncology
. 2018 Jul 3;30(3):495. doi: 10.1093/annonc/mdy221

Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer

M J Overman, L Adam, K Raghav, J Wang, B Kee, D Fogelman, C Eng, E Vilar, R Shroff, A Dasari, R Wolff, J Morris, E Karunasena, T R Pisanic II, N Azad, S Kopetz
PMCID: PMC6442652  PMID: 29982323

Ann Oncol 2018; 29: 139–144 (doi:10.1093/annonc/mdx688)

In the original article, author T. R. Pisanic II’s name was incorrectly spelt as ‘R. Pisanic II’. This has now been corrected.

Articles from Annals of Oncology are provided here courtesy of Oxford University Press

RESOURCES